Germinal centre-driven maturation of B cell response to SARS-CoV-2 mRNA vaccination. Homo sapiens
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Germinal centre-driven maturation of B cell response to SARS-CoV-2 mRNA vaccination
应用场景：
创建时间：
2021-11-04
相关数据集
Table_3_A rapid method for isolation of bacterial extracellular vesicles from culture media using epsilon-poly-L–lysine that enables immunological function research.xlsx
Both Gram-negative and Gram-positive bacteria can release vesicle-like structures referred to as bacterial extracellular vesicles (BEVs), which contain various bioactive compounds. BEVs play important
NIAID Data Ecosystem130
TMT labeled Comparative Proteomic Analysis Reveals Active Immune Response during Clostridium perfringens type C Infected Piglet Diarrhea
We performed a TMT labeling-based quantitative spleen proteomic analysis of the control group (SC), tolerance group (SR) and susceptible group (SS) to identify the differentially expressed proteins (D
NIAID Data Ecosystem70
Data_Sheet_1_Immune Profile of SARS-CoV-2 Variants of Concern.ZIP
The spread of the current Sars-Cov-2 pandemics leads to the development of mutations that are constantly monitored because they could affect the efficacy of vaccines. Three recently identified mutated
NIAID Data Ecosystem30
Additional file 3 of Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
Additional file 3. Log2 Median fluorescence intensity values for each SARS-CoV-2 peptide.
DataCite Commons2021-07-26 更新90
Single cell RNA sequencing analysis of bronchoalveolar lavage following SARS-CoV-2 B.1.351/beta variant challenge in mRNA-1273 vaccinated Rhesus macaques. Single cell RNA sequencing analysis of bronchoalveolar lavage following SARS-CoV-2 B.1.351/beta variant challenge in mRNA-1273 vaccinated Rhesus macaques
Single cell RNA sequencing analysis was performed on bronchoalveolar lavage samples obtained from Rhesus macaques on day 2 after intranasal/intratracheal infection with SARS-CoV-2 B.1.351/beta variant
NIAID Data Ecosystem30
